At the news
? BEARISHIMPACT 6/10 8-K filed Nov 6, 2026 at 16:30 ET
Jaguar Health stockholders approved all six proposals at a special meeting, including issuance of shares upon exchange of Series Q Preferred Stock and CVP Debt, repricing of warrants to $1.00, increasing the 2014 Stock Incentive Plan by 378,859 shares, a reverse stock split (ratio 1:2 to 1:150), reducing the ELOC floor price from $16.50 to $1.10, and adjournment authority. The reverse stock split was approved under the votes cast standard but not under the majority of outstanding standard. The approvals enable potential dilution and capital structure changes for a micro-cap biotech with a $7M market cap.
- All six proposals approved by stockholders at November 6, 2026 special meeting.
- Proposal 1: Issuance of common shares upon exchange of Series Q Preferred Stock and CVP Debt approved (1,770,099 for, 133,740 against).
- Proposal 2: Repricing of warrants with exercise prices $525-$3,996.60 to $1.00 per share approved (2,424,969 for, 136,390 against).
- Proposal 3: 2014 Stock Incentive Plan increased by 378,859 shares (14% of fully diluted shares) approved (2,217,959 for, 339,417 against).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access